Science Explorer Back to mapMap
Discussion
Researcher · Jena University Hospital · Germany

Lars‐Olof Mügge

Lars‐Olof Mügge publishes mostly in Hematology, Molecular Biology and Oncology, on topics such as Multiple Myeloma Research and Treatments, Cancer Treatment and Pharmacology and Protein Degradation and Inhibitors.

OpenAlex
World rank
#6,601,821
of 7,710,434 ranked researchers
Rank in Germany
#330,825
of 364,343
Works
53
Citations
484
Citations per work
9.1
h-index
13
i10-index 14Top 45% in Hematology
Lars‐Olof Mügge

What does Lars‐Olof Mügge research?

Lars‐Olof Mügge's work is mostly in Medicine (60%), Biochemistry, Genetics and Molecular Biology (17%).

Health Sciences: 32 works · 59.9% of their workMedicine: 32 works · 59.9% of their workHematology: 18 works · 33.8% of their workOncology: 8 works · 15.2% of their workPulmonary and Respiratory Medicine: 2 works · 4.1% of their workEpidemiology: 2 works · 3.4% of their workGenetics: 2 works · 3.4% of their workEverything else: 12 works · 22.9% of their workLife Sciences: 9 works · 17.2% of their workBiochemistry, Genetics and Molecular Biology: 9 works · 17.2% of their workMolecular Biology: 9 works · 17.2% of their workTHEIR WORKLars‐Olof Mügge53works
Life Sciences17%Health Sciences60%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine3259.9%
  2. Everything else1222.9%
    1. Biochemistry, Genetics and Molecular Biology917.2%
  1. 1Hematology34% of their works
  2. 2Molecular Biology17% of their works
  3. 3Oncology15% of their works
  4. 4Pulmonary and Respiratory Medicine4% of their works
  5. 5Epidemiology3% of their works
  6. 6Genetics3% of their works

Research topics

Which keywords describe Lars‐Olof Mügge's research?

The keywords of their largest research topics: Diagnosis Criteria, International Myeloma Working Group, Hematopoietic Stem Cells, Chemotherapy-Induced Peripheral Neuropathy, Taxanes, BET Bromodomains, PROTACs and Acute Myeloid Leukemia.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 17 words, with their numbers
  1. Diagnosis Criteria291 topic
  2. International Myeloma Working Group291 topic
  3. Hematopoietic Stem Cells132 topics
  4. Chemotherapy-Induced Peripheral Neuropathy111 topic
  5. Taxanes111 topic
  6. BET Bromodomains101 topic
  7. PROTACs101 topic
  8. AML71 topic
  9. Acute Myeloid Leukemia71 topic
  10. Bone Marrow Niche61 topic
  11. Graft-versus-Host Disease61 topic
  12. BCR-ABL51 topic
  13. Imatinib51 topic
  14. DNA41 topic
  15. HDAC Inhibitors41 topic
  16. Histone Deacetylases41 topic
  17. Topoisomerases41 topic

Where does Lars‐Olof Mügge work?

Lars‐Olof Mügge's main affiliation in the publication record is Jena University Hospital, Germany.

How many publications and citations does Lars‐Olof Mügge have?

OpenAlex counts 53 works and 484 citations for Lars‐Olof Mügge, an h-index of 13, ranking #6,601,821 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Lars‐Olof Mügge. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.